Ethambutol 100mg tablets

Land: Storbritannia

Språk: engelsk

Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)

Kjøp det nå

Last ned Preparatomtale (SPC)
03-12-2019

Aktiv ingrediens:

Ethambutol hydrochloride

Tilgjengelig fra:

DE Pharmaceuticals

ATC-kode:

J04AK02

INN (International Name):

Ethambutol hydrochloride

Dosering :

100mg

Legemiddelform:

Oral tablet

Administreringsrute:

Oral

Klasse:

No Controlled Drug Status

Resept typen:

Valid as a prescribable product

Produkt oppsummering:

BNF: 05010900

Informasjon til brukeren

                                By reporting side effects you can help provide more information on
the safety of this medicine.
Intrapharm Laboratories Ltd., The Courtyard Barns, Choke Lane,
Maidenhead, Berks SL6 6PT, UK
Intrapharm Laboratories Ltd., The Courtyard Barns, Choke Lane,
Maidenhead, Berks SL6 6PT, UK
Play or Apple App Store.
145.00 mm
277.50 mm
                                
                                Les hele dokumentet
                                
                            

Preparatomtale

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ethambutol 100 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film coated tablet contains 100mg Ethambutol Hydrochloride.
For a full list of excipients see section 6.1.
3
PHARMACEUTICAL FORM
Film coated tablet.
Smooth, yellow, circular, biconvex film coated tablet, plain on both
sides.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
The primary treatment and re-treatment of tuberculosis and for
prophylaxis in
cases of inactive tuberculosis or large-tuberculinpositive reaction.
Ethambutol
should only be used in conjunction with other anti-tuberculous drugs
to which
the patient’s organisms are susceptible.
Consideration should be given to official guidance on the appropriate
use of
antibacterial agents
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Route of administration_:
Oral
_Posology: _
Recommended Dosage
The dosage of ethambutol must be adjusted according to the body weight
of
the patient.
This drug should not be used as a sole anti-tuberculosis agent, but
should be
given with at least one other antituberculosis drug to avoid
development of
resistant strains.
The usual daily dosage is 15-25mg/kg body weight given as a single
dose.
_ _
_ADULTS _
For primary treatment and prophylaxis: Ethambutol should be
administered in
a single daily dose of 15mg/kg, concomitant drugs being maintained at
their
recommended dosage levels.
For re-treatment: For the first 60 days of treatment, ethambutol
should be
administered in a single daily dose of 25mg/kg. Thereafter the dosage
should
be
reduced
to
15mg/kg,
concomitant
drugs
being
maintained
at
their
recommended dosage levels.
_CHILDREN _
For primary treatment and re-treatment: For the first 60 days of
treatment, a
single daily oral dose of 25mg/kg. Thereafter the dosage should be
reduced to
15mg/kg, concomitant drugs being maintained at their recommended
dosage
levels._ _
For prophylaxis: A single daily oral dose of 15mg/kg, concomitant
drugs
being used at their recommended dosage levels
As chil
                                
                                Les hele dokumentet
                                
                            

Søk varsler relatert til dette produktet